Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study

Istituto Oncologico Veneto IRCCS

Status: Completed

Conditions: Solid Tumor, Adult

Study type: Observational

Funder types: Other

Identifiers

NCT04811781

Rovid

Details and patient eligibility

About

The study aims to retrospectively collect epidemiological and clinical data in patients with solid tumors and SARS Covid2 infections belonging to oncology centers within the Veneto Oncology Network

Full description

The aim of this study is to create a Veneto Oncology Network with the aim of collecting clinical and epidemiological data of cancer Patients affected by SAR- Covid-2 infection over a period of 1 year. Descriptive statistical approaches will be used to process the data.

The aim is to evaluate the development rate of severe clinical forms of infection in patients with SARS-Cov-2 and the possible association with tumour characteristics and treatment.

In addition, the results of serological tests can be compared with the outcome of the diagnostic swabs and the clinical evolution of the infection in order to obtain more information regarding the significance of specific antibody development.

Enrollment: 761 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• be 18 Years and older
• cancer patients belonging to Veneto 's Oncological Network
• Patients with SAR COV-2 infection

Exclusion criteria

• Patients with no SAR COV2 Infection
• Volunteers
• No Cancer Patients

Trial design

761 participants in 1 patient group

Cancer Patients with SARS-COV-2 infection.